Search research articles
Contact Us
Filters
Showing results (221-230 of 273) with videos related to
Page
of 28
Sort By:
Journal of Medicinal Chemistry
|
December 1, 1986
p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects
J G Cannon, V E Amoo, J P Long, et al.
Research Communications in Chemical Pathology and Pharmacology
|
September 1, 1976
Dopaminergic activity of some apomorphine analogs
H C Cheng, J P Long, L S Van Orden, et al.
European Journal of Pharmacology
|
June 27, 1980
Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs
T Verimer, J P Long, D R Rusterholz, et al.
Psychopharmacology
|
January 1, 1981
Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats
T Verimer, S P Arnerić, J P Long, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1974
Differential effect of metabolic inhibitors on myogenic tone and contractility in isolated tibial arteries
S Greenberg, D C Heitz, M J Brody, et al.
Molecular Carcinogenesis
|
September 6, 2000
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines
C Rauh-Adelmann, K M Lau, N Sabeti, et al.
Journal of Medicinal Chemistry
|
September 1, 1989
Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists
J G Cannon, C D True, J P Long, et al.
Journal of Medicinal Chemistry
|
March 1, 1978
Preparation and biological actions of some symmetrically N,N-disubstituted dopamines
J G Cannon, F L Hsu, J P Long, et al.
Journal of Medicinal Chemistry
|
February 1, 1984
Resorcinol congeners of dopamine derived from benzocycloheptene and indan
J G Cannon, J P Pease, R L Hamer, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1981
Peripheral vascular effects of a new dopamine analog: 5-6-dihydroxy-2-methylaminotetralin (M-8)
W Maixner, J P Long, C B Wright, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 273) with videos related to
Sort By:
Page
of 28
Journal of Medicinal Chemistry
|
December 1, 1986
p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects
J G Cannon, V E Amoo, J P Long, et al.
Research Communications in Chemical Pathology and Pharmacology
|
September 1, 1976
Dopaminergic activity of some apomorphine analogs
H C Cheng, J P Long, L S Van Orden, et al.
European Journal of Pharmacology
|
June 27, 1980
Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs
T Verimer, J P Long, D R Rusterholz, et al.
Psychopharmacology
|
January 1, 1981
Effects of ovariectomy, castration, and chronic lithium chloride treatment on stereotyped behavior in rats
T Verimer, S P Arnerić, J P Long, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1974
Differential effect of metabolic inhibitors on myogenic tone and contractility in isolated tibial arteries
S Greenberg, D C Heitz, M J Brody, et al.
Molecular Carcinogenesis
|
September 6, 2000
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines
C Rauh-Adelmann, K M Lau, N Sabeti, et al.
Journal of Medicinal Chemistry
|
September 1, 1989
Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists
J G Cannon, C D True, J P Long, et al.
Journal of Medicinal Chemistry
|
March 1, 1978
Preparation and biological actions of some symmetrically N,N-disubstituted dopamines
J G Cannon, F L Hsu, J P Long, et al.
Journal of Medicinal Chemistry
|
February 1, 1984
Resorcinol congeners of dopamine derived from benzocycloheptene and indan
J G Cannon, J P Pease, R L Hamer, et al.
Journal of Cardiovascular Pharmacology
|
March 1, 1981
Peripheral vascular effects of a new dopamine analog: 5-6-dihydroxy-2-methylaminotetralin (M-8)
W Maixner, J P Long, C B Wright, et al.
Page
of 28